Okay, let's tackle this question. The user provided a question about managing a hemodynamically stable patient with a broad QRS complex and antidromic tachycedaria. First, I need to recall what antidromic tachycardia is. Oh right, it's a type of supraventricular tachycardia (SVT) but with a different conduction pathway. The key here is that it involves the AV node and an accessory pathway, but the impulse goes the opposite direction through the accessory pathway.

So the core concept here is about differential diagnosis of wide complex tachycardias. The options likely include various treatments, but since the patient is stable, the management would be different from unstable cases. For unstable, you'd use synchronized cardioversion, but for stable, you might consider medications.

Antidromic tachycardia is usually a form of WPW (Wolff-Parkinson-White) syndrome, right? The accessory pathway allows the impulse to bypass the AV node, leading to a faster conduction. The treatment for SVT in WPW can be tricky because some medications might actually be dangerous. For example, calcium channel blockers or adenosine could accelerate the ventricular rate if the reentry is using the accessory pathway, leading to ventricular fibrillation.

So the correct answer would be something that's safe in WPW. Procainamide or amiodarone are options. Adenosine is contraindicated here because it blocks the AV node, but if the reentry is using the accessory pathway, blocking the AV node might send the impulse through the accessory pathway faster. So adenosine is dangerous in this scenario. Therefore, the correct management would be to use an agent that inhibits the accessory pathway, like procainamide.

Now, looking at the options, the correct answer is probably C or D, assuming those are procainamide or amiodarone. The incorrect options would include adenosine, calcium channel blockers, or maybe even synchronized cardioversion if the patient is stable, but since they're stable, cardioversion isn't the first choice.

So the clinical pearl here is to remember that in WPW with antidromic tachycardia, adenosine is contraindicated. The high-yield fact is to avoid agents that block the AV node and instead use those that block the accessory pathway.

**Core Concept** Antidromic tachycardia is a type of supraventricular tachycardia (SVT) in Wolff-Parkinson-White (WPW) syndrome, characterized by retrograde conduction through an accessory pathway. Management depends on hemodynamic stability and the risk of precipitating ventricular fibrillation.

**Why the Correct Answer is Right** In antidromic tachycardia, the impulse travels anterograde through the AV node and retrograde through the accessory pathway. Adenosine, calcium channel blockers, or beta-blockers risk accelerating conduction via the accessory pathway. **Procainamide** is preferred as it suppresses accessory pathway conduction and prolongs the refractory period, safely controlling the rhythm without risking ventricular fibrillation.

**Why Each Wrong Option is Incorrect**
**Option A:** *Adenosine* is contraindicated in WPW with antidromic tachycardia; it

✓ Correct Answer: D. Intravenous Procainamide